32 results on '"Whitaker, P."'
Search Results
2. Research in progress---electronic patient records: a new era.
3. 231 Are adult cystic fibrosis patients aware of the importance of skin health and sun protection?
4. 121 Extended HLA analysis in a cohort of patients hypersensitive to beta-lactam antibiotics.
5. ePS2.03 Diagnosis and treatment of pulmonary embolismin adult patients with cystic fibrosis.
6. Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series.
7. Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: Real life experience of a large adult CF centre.
8. Detection of drug-responsive B lymphocytes and antidrug IgG in patients with β-lactam hypersensitivity.
9. In vitro tests for drug hypersensitivity reactions: an ENDA/ EAACI Drug Allergy Interest Group position paper.
10. 42 Dramatic clinical stabilisation following introduction of ivacaftor in an adult patient with cystic fibrosis (CF) and R117H/5T mutation.
11. 49 The use of positron emission tomography (PET) in adult patients with cystic fibrosis (CF).
12. 101 Survival of Mycobacterium abscessus in artificially generated aerosols.
13. HLA-DQ allele-restricted activation of nitroso sulfamethoxazole-specific CD4-positive T lymphocytes from patients with cystic fibrosis.
14. 33 Procalcitonin and C reactive protein levels in hospitalised patients receiving intravenous antibiotics.
15. 199 Metabolic alkalosis in patients with cystic fibrosis: Are we missing something?
16. Occupational anaphylaxis - an EAACI task force consensus statement.
17. The development and deployment of integrated electronic care records in a regional adult and paediatric cystic fibrosis unit.
18. ePS5.02 The effect of providing patient online access to Electronic Health care Records (EHR) in cystic fibrosis.
19. ePS2.04 Indications and complications of NIV in patients with cystic fibrosis: 10-year experience in a large UK adult CF centre.
20. P253 Use of ivacaftor (IVA) in patients heterozygous for R117H mutation: real-life experience in a large UK adult CF centre.
21. P255 Clinical stabilisation following ivacaftor in patients with cystic fibrosis, severe lung disease and rare CFTR mutation: a report of two cases.
22. P250 Pattern of use of NIV: 10-year experience of a large UK adult cystic fibrosis centre.
23. WS11-4 Current clinical practice in the management of cystic fibrosis-related bone disease in a regional UK adult cystic fibrosis centre.
24. WS05-2 Empowering patients with cystic fibrosis to participate in the administration of intravenous antibiotics in hospital.
25. 183 Clinical efficacy, tolerability and safety of IV fosfomycin: experience of a UK adult cystic fibrosis (CF) centre.
26. EPS3.10 Pregnancy in women with CF: Improved clinical outcomes 1990–2016.
27. 134 Does Pandoraea cause clinical deterioration in adults with cystic fibrosis?
28. 288 Losartan-associated sprue-like enteropathy in a post-lung transplant cystic fibrosis patient.
29. 56 Early experience of the Orkambi “Managed Access Programme” in a regional adult UK CF centre.
30. Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy.
31. WS16.4 What functionality do patients want from an Electronic Clinical Record (ECR).
32. 22 Defining the cystic fibrosis arthropathy phenotype: A serological and imaging pilot study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.